Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 320,678 | 173,858 | 69,420 | -224,060 | 16,664 |
| Depreciation Amortization | 479,495 | 316,937 | 157,360 | 629,471 | 484,740 |
| Income taxes - deferred | -224,317 | -145,395 | -66,061 | -292,251 | -146,874 |
| Accounts receivable | 23,581 | 42,439 | 28,460 | -90,135 | -43,868 |
| Accounts payable and accrued liabilities | 17,705 | 7,462 | 34,286 | -11,225 | 4,188 |
| Other Working Capital | -23,431 | 1,117 | 18,324 | 9,905 | -48,921 |
| Other Operating Activity | 330,957 | 221,055 | 78,919 | 1,250,272 | 664,077 |
| Operating Cash Flow | $924,668 | $617,473 | $320,708 | $1,271,977 | $930,006 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -250,000 | -80,000 | 0 | -1,036 | -61,036 |
| PPE Investments | -13,860 | -9,561 | -3,822 | -29,046 | -19,668 |
| Net Acquisitions | N/A | N/A | N/A | 53,000 | 53,000 |
| Purchase Sale Intangibles | -1,000 | -1,000 | -1,000 | -469,148 | -94,148 |
| Other Investing Activity | -1,000 | -1,000 | -1,000 | -469,148 | -94,148 |
| Investing Cash Flow | $-264,860 | $-90,561 | $-4,822 | $-446,230 | $-121,852 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -23,250 | -15,500 | -7,750 | -582,014 | -574,264 |
| Common Stock Issued | 37,606 | 32,094 | 21,228 | 98,020 | 67,863 |
| Common Stock Repurchased | -169,966 | -95,595 | N/A | -54 | -54 |
| Other Financing Activity | -49,338 | -47,454 | -43,266 | -45,443 | -42,632 |
| Financing Cash Flow | $-204,948 | $-126,455 | $-29,788 | $-529,491 | $-549,087 |
| Exchange Rate Effect | -652 | 365 | 331 | -6,222 | -11,157 |
| Beginning Cash Position | 881,482 | 881,482 | 881,482 | 591,448 | 591,448 |
| End Cash Position | 1,335,690 | 1,282,304 | 1,167,911 | 881,482 | 839,358 |
| Net Cash Flow | $454,208 | $400,822 | $286,429 | $290,034 | $247,910 |
| Free Cash Flow | |||||
| Operating Cash Flow | 924,668 | 617,473 | 320,708 | 1,271,977 | 930,006 |
| Capital Expenditure | -13,860 | -9,561 | -3,822 | -29,046 | -19,668 |
| Free Cash Flow | 910,808 | 607,912 | 316,886 | 1,242,931 | 910,338 |